How Big Pharma games the system — and keeps drugs prices high

Layers of market protections and courtroom tricks keep competitors off the market far longer than rules intended, say generics firms.

Related Keywords

Italy ,United States ,Germany ,Poland ,Borrat ,Baden Wüberg ,American , ,Amgen ,European Commission ,A European Parliament ,European Consumer Organisation ,European Patent Office ,European Medicines Agency ,Europe Patent Office ,Big Pharma ,Patent Office ,European Patent ,European Parliament ,Eastern European ,Adrian Van Den Hoven ,Business And Competition ,Companies ,Courts ,Drug And Device Safety ,Eu27 ,Generics And Biosimilars ,Genetics ,Innovation ,Manufacturing ,Medicines ,Patents ,Patients ,Personalized Medicines ,Pharma ,Public Health ,Rare Diseases ,Regulation ,